PMID: 8610223Jan 1, 1995Paper

Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease

Scandinavian Journal of Rheumatology
K OzoranG Tokgöz

Abstract

Sixty-three patients with Behçet's disease (BD), 30 patients with recurrent oral ulcer and 30 healthy individuals as control group were included in the study. ISG criteria was used for the diagnosis of BD and patients were classified as active and inactive and evaluated accordingly. In the patient and control groups, von Willebrand factor (vWF), tissue plasminogen activator (tPA), and plasminogen activator inhibitor (PAI) levels were determined using ELISA method and antithrombin III (AT-III) by nephelometric methods. High levels of endothelial product, vWF in the active Behçet patient group (p < 0.005) supports endothelial destruction due to vasculitis related with BD. In the active patient group tPA levels were significantly lower (p < 0.05) than the inactive and control groups with higher levels of PAI (p < 0.05 and p < 0.01) respectively. In Behçet disease, besides the decrease in tPA synthesis, high PAI levels also can affect tPA decrease and lead to inhibition of fibrinolytic activity. In active Behçet group, levels of AT-III were low and no significant difference was observed in recurrent oral ulcer and control groups. This situation may arise from the excessive use of AT-III in active disease. In conclusion, high levels...Continue Reading

References

Aug 1, 1992·Annals of the Rheumatic Diseases·E J BrommerF C Breedveld
Oct 1, 1991·British Journal of Rheumatology·A D BlannP Emery
Jul 1, 1991·The Journal of Antimicrobial Chemotherapy·M D Richardson
Dec 1, 1990·Annals of the Rheumatic Diseases·L MussoniA Martini
Oct 1, 1990·Journal of the American Academy of Dermatology·J L Jorizzo, R S Rogers
Feb 1, 1990·The New England Journal of Medicine·H YaziciG E Lovatt
Apr 1, 1989·International Journal of Radiation Oncology, Biology, Physics·N M BleehenP Workman
Nov 1, 1987·British Journal of Orthodontics·H S Orton
Feb 1, 1986·Arthritis and Rheumatism·N SuzukiT Tsunematsu
Oct 1, 1987·Annals of the Rheumatic Diseases·M A ByronS A Cederholm-Williams
May 1, 1986·International Journal of Dermatology·A U MüftüoğluS Deniz
Mar 1, 1986·Postgraduate Medical Journal·D G James
Mar 1, 1985·International Ophthalmology·J Mullaney, L M Collum
Sep 1, 1993·Clinical Rheumatology·E A MurphyH A Capell
Jul 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S ChatzipanagiotouE Malamou-Lada

❮ Previous
Next ❯

Citations

Oct 31, 2003·Rheumatology International·Aşkin AteşMurat Duman
Aug 17, 2004·Rheumatology International·Seung Woo HanYoung Mo Kang
Mar 2, 2005·Rheumatology International·Meral KayikçioğluEker Doganavsargil
Sep 14, 2006·Rheumatology International·Seong Ryul KwonWon Park
Apr 3, 2004·Trends in Molecular Medicine·Beatrice Cambien, Denisa D Wagner
Mar 6, 1997·The American Journal of Cardiology·A P SelwynP Ganz
Nov 5, 1997·Contraception·M ShaarawyM Sheiba
May 23, 2001·Thrombosis Research·P Y ScarabinUNKNOWN PRIME Study Group
Apr 18, 2002·Thrombosis Research·Sedat KirazMeral Calgüneri
Aug 8, 2002·Thrombosis Research·Yun Jong LeeYeong Wook Song
Jun 24, 2003·Thrombosis Research·Francisco MarínGregory Y H Lip
Nov 1, 2003·Veterinary Immunology and Immunopathology·Anna MassaguerPilar Pizcueta
Sep 18, 2004·Archives of Gerontology and Geriatrics·A SuehiroE Kakishita
Jun 7, 2000·Journal of the American College of Cardiology·F L Li-Saw-HeeG Y Lip
Feb 24, 2001·Journal of the American College of Cardiology·J C ChambersJ S Kooner
Dec 29, 2010·Biochemistry Research International·Amira HamzaouiSilvia Mahjoub
Dec 4, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Moncef FekiNeziha Kaabachi
Apr 3, 2010·The Open Cardiovascular Medicine Journal·Micaela La ReginaDomenico Prisco
Dec 30, 2014·The Egyptian Journal of Internal Medicine·Jihen AyariRachid Mechmeche
Mar 31, 2004·The Lancet Infectious Diseases·Katleen de Gaetano DonatiRoberto Cauda
Aug 13, 2013·Case Reports in Rheumatology·Nurşen DüzgünAşkın Ateş
May 3, 2015·The American Journal of Case Reports·Yılmaz BaşAyşegül Taylan Özkan
Apr 18, 2015·Thrombosis Journal·Giacomo EmmiDomenico Prisco
Dec 29, 2011·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M Cem ArHasan Yazici
Jan 29, 2002·The American Journal of Medicine·Gerard EspinosaJoan-Carles Reverter
Oct 9, 2007·La Revue de médecine interne·L El FekihM Doggi
Feb 10, 2006·Scandinavian Journal of Rheumatology·N DüzgünU Olmez
Jan 31, 2006·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Meral CalgüneriIhsan Ertenli
Jul 18, 2018·Scandinavian Journal of Clinical and Laboratory Investigation·Erdim SertogluTaner Ozgurtas
Oct 19, 2007·The British Journal of Dermatology·J-Y JungD Bang
Jun 21, 2008·The British Journal of Dermatology·S-H OhD Bang
Jun 29, 2007·Journal of Korean Medical Science·Moo-Yong RheeSeong-Kyu Kim
Apr 7, 2018·The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology·Ba Djibril MarieFall Moussa Daouda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.